1. Home
  2. GRAF vs SERA Comparison

GRAF vs SERA Comparison

Compare GRAF & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRAF
  • SERA
  • Stock Information
  • Founded
  • GRAF 2021
  • SERA 2008
  • Country
  • GRAF United States
  • SERA United States
  • Employees
  • GRAF N/A
  • SERA N/A
  • Industry
  • GRAF
  • SERA Precision Instruments
  • Sector
  • GRAF
  • SERA Health Care
  • Exchange
  • GRAF NYSE
  • SERA Nasdaq
  • Market Cap
  • GRAF 288.1M
  • SERA 258.3M
  • IPO Year
  • GRAF 2024
  • SERA 2021
  • Fundamental
  • Price
  • GRAF $10.01
  • SERA $6.74
  • Analyst Decision
  • GRAF
  • SERA
  • Analyst Count
  • GRAF 0
  • SERA 0
  • Target Price
  • GRAF N/A
  • SERA N/A
  • AVG Volume (30 Days)
  • GRAF 45.1K
  • SERA 65.6K
  • Earning Date
  • GRAF 01-01-0001
  • SERA 11-06-2024
  • Dividend Yield
  • GRAF N/A
  • SERA N/A
  • EPS Growth
  • GRAF N/A
  • SERA N/A
  • EPS
  • GRAF N/A
  • SERA N/A
  • Revenue
  • GRAF N/A
  • SERA $94,000.00
  • Revenue This Year
  • GRAF N/A
  • SERA N/A
  • Revenue Next Year
  • GRAF N/A
  • SERA $2,018.04
  • P/E Ratio
  • GRAF N/A
  • SERA N/A
  • Revenue Growth
  • GRAF N/A
  • SERA N/A
  • 52 Week Low
  • GRAF $9.03
  • SERA $1.65
  • 52 Week High
  • GRAF $11.02
  • SERA $12.36
  • Technical
  • Relative Strength Index (RSI)
  • GRAF N/A
  • SERA 43.20
  • Support Level
  • GRAF N/A
  • SERA $7.56
  • Resistance Level
  • GRAF N/A
  • SERA $8.78
  • Average True Range (ATR)
  • GRAF 0.00
  • SERA 0.64
  • MACD
  • GRAF 0.00
  • SERA -0.00
  • Stochastic Oscillator
  • GRAF 0.00
  • SERA 17.74

About GRAF GRAF GLOBAL CORP

Graf Global Corp is a blank check company.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.

Share on Social Networks: